Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Prime Medicine, Inc.Listing on record | Buy | $20M | conv 61ClusterFirst in 12mo | SEC | |
Neumora Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Neumora Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC |